Yes, mind boggling that the same doomer/whingers here in own company reached a valuation of over A$3.5B with claims of 1000+ patients in trials at time, and hardly any more since (2 years + since Covid ARDs stopped)....but still no US approval.....and just 55 in that GvHD trial...
Cynata catching up really fast!
and ours with far superior harvesting and expansion tech + superior consistency and potency. 29m/30m doses possible from one bank so far....
Those same doomers had they listened to their own head of manufacturing in 2020 stating they would struggle with 10,000 doses in 6 months (got the boot) and STILL using bovine serum LOL.....might just wake up one day at the value and tech here
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)